Characteristics of 15,285 new initiators of systemic glucocorticoids, according to whether they received high-quality GIOP preventive care.
| Characteristics | Received High-quality GIOP Preventive Care, n = 3898 (%) | Did Not Receive High-quality GIOP Preventive Care, n = 11,927 (%) | p |
|---|---|---|---|
| Age, yrs | < 0.001 | ||
| < 50 | 714 (18) | 3755 (31) | |
| 50–59 | 805 (21) | 1739 (15) | |
| 60–69 | 850 (22) | 2158 (18) | |
| ≥ 70 | 1529 (39) | 4275 (36) | |
| Female | 3031 (78) | 6154 (52) | < 0.001 |
| Urban residence | 2582 (66) | 7595 (64) | 0.004 |
| Burden of comorbidities | < 0.001 | ||
| ≤ 2 ADG | 172 (4) | 980 (8) | |
| 3–5 ADG | 1050 (27) | 3861 (33) | |
| > 5 ADG | 2676 (69) | 7086 (59) | |
| Frailty indicators (prior 1 yr) | |||
| > 1 hospitalization | 448 (12) | 1430 (12) | 0.6 |
| Any homecare visit | 236 (6) | 640 (5) | 0.1 |
| Glucocorticoid exposures | |||
| High dose (> 10 mg/day) | 1296 (33) | 3459 (29) | < 0.001 |
| Remote prior initiation | 248 (6) | 603 (5) | 0.002 |
GIOP: glucocorticoid-induced osteoporosis; ADG: aggregated diagnosis groups.